Bellerophon Therapeutics, Inc.
BLPHDelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001600132
Bellerophon Therapeutics, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Oct 16, 2023; 22 institutions reported holding it in 13F filings for Q3 2023, worth $506.6K in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Bellerophon Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 23 | 22 | −1 |
| Shares | 1.20M | 1.27M | +75.4K (+6.3%) |
| Value | $824.9K | $506.6K | −$318.4K (−38.6%) |
New holders (4)
Institutions that held Bellerophon Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 42,717 | $17.1K | 0.00% |
| Susquehanna International Group, LLP | 15,313 | $6.13K | 0.00% |
| Qube Research & Technologies Ltd | 52 | $21 | 0.00% |
| Global Wealth Strategies & Associates | 50 | $20 | 0.00% |
Sold out (5)
Institutions that held Bellerophon Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Virtu Financial LLC | 25,870 | $18.0K |
| Two Sigma Securities, LLC | 10,355 | $7.14K |
| Royal Bank of Canada | 192 | $0 |
| Simplex Trading, LLC | 95 | $0 |
| Sofos Investments, Inc. | 1 | – |